![Richard Pulik](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Richard Pulik
Director of Finance/CFO at
ROIVANT SCIENCES LTD.
Net worth: 8 M $ as of 2026-05-30
Profile
Currently, Richard Pulik holds the position of Chief Financial Officer for Roivant Sciences Ltd. and Chief Financial Officer for Roivant Sciences, Inc. (a subsidiary of Roivant Sciences Ltd.). In the past Mr. Pulik was Global Head-Business Development & Licensing at Novartis Pharmaceuticals Corp. He received an undergraduate degree from the University of Pennsylvania and an undergraduate degree from The Wharton School of the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-19 | 276,420 ( 0.04% ) | 8 M $ | 2026-05-30 |
Richard Pulik active positions
| Companies | Position | Start |
|---|---|---|
| ROIVANT SCIENCES LTD. | Director of Finance/CFO | 2021-09-27 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Director of Finance/CFO | 2021-09-27 |
Former positions of Richard Pulik
| Companies | Position | End |
|---|---|---|
| NOVARTIS AG | Investor Relations Contact | 2019-07-31 |
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Corporate Officer/Principal | - |
Training of Richard Pulik
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
93
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Roivant Sciences Ltd.
 Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
- Stock Market
- Insiders
- Richard Pulik
